Position in VERU
as of Mar 31, 2026
· filed Apr 28, 2026
Position Value
$1,672
+$665 QoQ
Shares Held
757
+60.7% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in VERU Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Quent Capital, LLC holds $1,203,336 across 36 Biotechnology names. VERU ranks #33 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
366 | $282,786 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
563 | $251,402 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
4,130 | $114,401 | |
| 4 | INSM |
INSMED Inc
|
616 | $100,728 | |
| 5 | MRVI |
Maravai Lifesciences Holdings, Inc.
|
30,000 | $84,900 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
307 | $58,038 | |
| 7 | INCY |
Incyte Corp
|
396 | $37,271 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
67 | $22,168 |
All Filings in VERU
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,672 | 757 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $1,007 | 471 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $923 | 243 | Shares | Sole | 2025-10-27 | |
| No filing history on record for this holder in this stock. | ||||||